Novel strategies for molecular targeting to cancer

Research output: Contribution to journalEditorialOtherpeer-review

Abstract

Summary: This editorial draws attention to the work published by CEPP in 2014-2015 on mechanisms underlying cancer drug resistance, invasion and metastasis. Genetic, genomic and immunological changes in platinum drug resistance and new drug candidates for cancer metastasis are highlighted. Attention is paid to the Epimedium plant drug icariin in glioblastoma invasion, the plant Avicennia marina bioactive compound Naphtho[1,2-b]furan-4,5-dione in breast cancer metastasis, the PI3K inhibitor BEZ235 in colon cancer stem cells, the histone methyltransferase EZH1 inhibitor GSK343 in cervical cancer, and vitamin D3 in prostate cancer.

Original languageEnglish
Pages (from-to)287-289
Number of pages3
JournalClinical and Experimental Pharmacology and Physiology
Volume43
Issue number3
DOIs
Publication statusPublished - 1 Mar 2016

Keywords

  • Cancer
  • Drug resistance
  • Metastasis

Cite this

@article{47a0da25f2da45299204c21b41b2a3a7,
title = "Novel strategies for molecular targeting to cancer",
abstract = "Summary: This editorial draws attention to the work published by CEPP in 2014-2015 on mechanisms underlying cancer drug resistance, invasion and metastasis. Genetic, genomic and immunological changes in platinum drug resistance and new drug candidates for cancer metastasis are highlighted. Attention is paid to the Epimedium plant drug icariin in glioblastoma invasion, the plant Avicennia marina bioactive compound Naphtho[1,2-b]furan-4,5-dione in breast cancer metastasis, the PI3K inhibitor BEZ235 in colon cancer stem cells, the histone methyltransferase EZH1 inhibitor GSK343 in cervical cancer, and vitamin D3 in prostate cancer.",
keywords = "Cancer, Drug resistance, Metastasis",
author = "Liu, {Jun Ping}",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/1440-1681.12556",
language = "English",
volume = "43",
pages = "287--289",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "3",

}

Novel strategies for molecular targeting to cancer. / Liu, Jun Ping.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 43, No. 3, 01.03.2016, p. 287-289.

Research output: Contribution to journalEditorialOtherpeer-review

TY - JOUR

T1 - Novel strategies for molecular targeting to cancer

AU - Liu, Jun Ping

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Summary: This editorial draws attention to the work published by CEPP in 2014-2015 on mechanisms underlying cancer drug resistance, invasion and metastasis. Genetic, genomic and immunological changes in platinum drug resistance and new drug candidates for cancer metastasis are highlighted. Attention is paid to the Epimedium plant drug icariin in glioblastoma invasion, the plant Avicennia marina bioactive compound Naphtho[1,2-b]furan-4,5-dione in breast cancer metastasis, the PI3K inhibitor BEZ235 in colon cancer stem cells, the histone methyltransferase EZH1 inhibitor GSK343 in cervical cancer, and vitamin D3 in prostate cancer.

AB - Summary: This editorial draws attention to the work published by CEPP in 2014-2015 on mechanisms underlying cancer drug resistance, invasion and metastasis. Genetic, genomic and immunological changes in platinum drug resistance and new drug candidates for cancer metastasis are highlighted. Attention is paid to the Epimedium plant drug icariin in glioblastoma invasion, the plant Avicennia marina bioactive compound Naphtho[1,2-b]furan-4,5-dione in breast cancer metastasis, the PI3K inhibitor BEZ235 in colon cancer stem cells, the histone methyltransferase EZH1 inhibitor GSK343 in cervical cancer, and vitamin D3 in prostate cancer.

KW - Cancer

KW - Drug resistance

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=84959326049&partnerID=8YFLogxK

U2 - 10.1111/1440-1681.12556

DO - 10.1111/1440-1681.12556

M3 - Editorial

VL - 43

SP - 287

EP - 289

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 3

ER -